Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Long-Read Sequencing Market Size to Reach USD 2,313.8 Million in 2028 | Rising Number of Genetic Disorders and Population Genomics is Driving Industry Demand, Says Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

30 Mar, 2022, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, BC, March 30, 2022 /PRNewswire/ -- The global long-read sequencing market size was USD 504.5 Million in 2020. Rapid adoption of genomic data analysis software is expected to boost market revenue growth during the forecast period.


Drivers: Growing number of genetic disorders

Long-read sequencing is one of the most intensive method, which is rapidly being used in whole genomic examination. Genomic data has proven to be instrumental in recognizing inherited disorders by characterizing mutations, which helps in cancer progression and tracking outbreak of infectious diseases. Moreover, this technique is also used in sequencing protein-coding genes in genome. These attributes are responsible for boosting adoption of long-read sequencing in treatment of genetic disorders.

Get Free Sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/982

Restraints: High cost of long-read sequencing procedure

Implication of long-read sequencing requires highly advanced genomic testing centers. Installation of such infrastructure requires huge capital investment. Moreover, change in climate and global atmosphere is causing rapid change in symptoms and treatment procedure of critical genomic diseases. Therefore, research and development procedures are adding to additional cost.

Growth Projections

The global long-read sequencing market size are expected to reach USD 2,313.8 Million at a revenue CAGR of 21.1% in 2028, according to latest report by Emergen. Increasing number of cancer patients and genomic diseases, which requires advanced treatment procedures, is boosting demand for long-read sequencing techniques all over the world.

COVID-19 Direct Impact

COVID-19 pandemic has severely affected human health across the world, and has caused several deaths. Health emergency was declared all over the globe which created long-term impact on this market. Frequent lockdowns and safety mandates implied by government of various countries created several obstacles such as slow research and development process, and shifting of focus from existing and new projects due to chaos. However, long-read sequencing market witnessed notable growth during this period. High demand for third generation sequencing to formulate COVID-19 vaccine has driven market revenue growth to its peak.

Discount Available on Long Read Sequencing market report [Click Here]@ https://www.emergenresearch.com/request-discount/982

Current Trends and Innovations

Continuous research and developments and upgradation of new technologies are creating new opportunities for the market. Rapid adoption of genomic data analysis software has enhanced power of third generation sequencing techniques by helping in analyzing genome-wide association studies. Various software such as expression networks, gene expression microarray software, BioPERL, and others assists researchers in exploring genetic variability and genetic structure with help of advanced statistical association models. This software is expected to build complicated genetic risk models, which is expected to help in understanding biological underpinning of diseases and health outcomes.

Geographical Outlook

European market is expected to register a significantly rapid revenue growth rate during the forecast period due to advancement in healthcare technologies and increasing adoption of third generation sequencing techniques across biotechnology laboratories, diagnostic centers, and forensic labs. Furthermore, combined initiatives by the European Government and state government authorities in developing countries are promoting adoption of long-read sequencing in virology research labs and academic research labs, which is expected to drive market revenue growth in this region.

Strategic Initiatives

In September 2020, Roche launched SARS-CoV-2 rapid antigen test, which is able to generate results within 15 minutes. It helps in taking fast triage decisions at point of care and provides infection status in a short period of time.

Some Key Highlights from the Report

  • Nanopore sequencing segment is expected to register a significantly robust revenue growth rate during the forecast period, owing to increasing use of this technique in long-read sequencing
  • Infectious disease segment is expected to register a significant growth rate during the forecast period, owing to long-term effect of COVID-19 pandemic. During the pandemic, long-read sequencing techniques are widely used in identification of origin of disease and in making of an antidote to stabilize the virus' effect.
  • Clinical laboratories segment accounted for a significantly large revenue share in 2020. Huge causality caused by COVID-19 pandemic and increasing number of genetic diseases and cancer patients all over the world has triggered adoption for long-read sequencing techniques in clinical laboratories.
  • Major companies in the global market report include Agilent Technologies, Inc., Beijing Genomics Institute (BGI) Genomics Co., Ltd., Bionano Genomics, Inc., Illumina, Inc., Longas Technologies Pty. Ltd., Novogene Co., Ltd., Oxford Nanopore Technologies, Inc., Pacific Biosciences of California, Inc., Quantapore, Inc., and PerkinElmer, Inc.

Explore Complete Report Description and Table of Contents of Long Read Sequencing Market Report@ https://www.emergenresearch.com/industry-report/long-read-sequencing-market

Emergen Research has segmented global long-read sequencing market on the basis of technology, products and services, application, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2018–2028)
    • Single-Molecule Real-Time (SMRT) Sequencing 
    • Nanopore Sequencing
    • Synthetic Long-Read Sequencing
    • Other Sequencing Technologies
  • Products and Services Outlook (Revenue, USD Million, 2018–2028)
    • Products

a.  Kits and Assays

b.  Systems

c.  Software

    • Consumables
    • Services
  • Application Outlook (Revenue, USD Million, 2018–2028)
    • Oncology
    • Infectious Diseases
    • Rare Diseases
    • Genetic Disorders
    • Metabolic Disorders
    • Translational Research
  • End Use Outlook (Revenue, USD Million, 2018–2028)
    • Academic and Research Institutions
    • Pharma and Biotech Companies
    • Clinical Laboratories
    • Hospitals and Clinics
    • Others

Get Customized Report as Per Your Specific Requirement@ https://www.emergenresearch.com/request-for-customization/982

  • ·  Regional Outlook (Revenue, USD Million, 2018–2028)
    • North America

a.  U.S.

b.  Canada

c.  Mexico

  •  
    • Europe

a.  Germany

b.  U.K.

c.  France

d.  Spain

e.  BENELUX

f.  Rest of Europe

  •  
    • Asia Pacific

a.  China

b.  India

c.  Japan

d.  South Korea

e.  Rest of APAC

  •  
    • Latin America

a.  Brazil

b.  Rest of LATAM

  •  
    • Middle East & Africa

a.  Saudi Arabia

b.  UAE

c.  Israel

d.  Rest of MEA

Latest Reports Published by Emergen Research:

Next Generation Ultrasound System Market, By Portability (Portable Systems, Trolley Based Systems, and Others), By Product Type (Therapeutic Ultrasound, Diagnostic Ultrasound), By Application, By Technology, By End-Use, and By Region Forecast to 2028.

Cell Expansion Market By Product (Consumables, Instruments, Bioreactors), By Cell Type (Mammalian, Microbial), By Application, By End-user, and By Region Forecast to 2027.

Medical Grade Tubing Market Size, Share, Trends, By Material (Polyvinyl Chloride, Polyolefin, Thermoplastic elastomer and thermoplastic polyurethane, Silicone), By Application (Bulk Disposable Tubing), By Structure and By Region Forecast to 2030.

3D Organ Printing Market, By Material (Living Cells, Hydrogels, Extracellular Matrices, Other Biomaterials), By Printing Component (Inkjet Printing, Extrusion Printing, Laser-Assisted Printing), By End-use, and By Region Forecast to 2030.

Immunocytokines Market Size, Share, Trends, By Disease Indication (Tumor and Cancer, Rheumatoid Arthritis), By Targeting Site (Liver, Hypothalamus, Fat Muscle, B and T Lymphocytes, Bone Marrow Endothelium), and By Region Forecast to 2028.

Pilates and Yoga Studios Market Size, Share, Trends, By Type (Yoga Classes, Pilates Classes, Pilates & Yoga Accreditation Training), By Application, By Enterprise Size, By Sales Channel, and By Region Forecast to 2030

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services

Read our Press Release on Long Read Sequencing @ https://www.emergenresearch.com/press-release/global-long-read-sequencing-market 

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.